Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 168 | 0 | 0 | 0 |
| Cost of Goods | N/A | 417 | N/A | N/A | N/A |
| Gross Profit | N/A | -249 | N/A | N/A | N/A |
| Operating Expenses | 0 | 2,588 | 0 | 1,928 | 1,823 |
| Operating Income | N/A | -2,420 | N/A | -1,928 | -1,823 |
| Interest Expense | 0 | 0 | 0 | 231 | -3,535 |
| Other Income | 0 | 12,875 | 0 | 0 | -4,042 |
| Pre-tax Income | 0 | 10,455 | 0 | -2,159 | -2,330 |
| Net Income Continuous | N/A | 10,455 | N/A | -2,159 | -2,330 |
| Net Income | $N/A | $10,455 | $N/A | $-2,159 | $-2,330 |
| EPS Basic Total Ops | N/A | 8.40 | N/A | -4.00 | N/A |
| EPS Basic Continuous Ops | N/A | 12.39 | N/A | -4.26 | -1.27 |
| EPS Diluted Total Ops | N/A | 8.40 | N/A | -4.00 | N/A |
| EPS Diluted Continuous Ops | N/A | 12.39 | N/A | -4.26 | -1.27 |
| EPS Diluted Before Non-Recurring Items | N/A | 8.40 | -3.57 | -4.00 | -240.00 |
| EBITDA(a) | $N/A | $-2,420 | $N/A | $-1,772 | $-1,739 |